tiprankstipranks
KalVista initiated with a Buy at JonesResearch
PremiumThe FlyKalVista initiated with a Buy at JonesResearch
2M ago
Pharvaris CBO Resigns, Team Absorbs Duties
Premium
Company Announcements
Pharvaris CBO Resigns, Team Absorbs Duties
2M ago
Pharvaris Refines License Terms with BRAIN Biotech
Premium
Company Announcements
Pharvaris Refines License Terms with BRAIN Biotech
2M ago
Pharvaris’ deucrictibant shows safety and tolerability in Phase 2 HAE study
PremiumThe FlyPharvaris’ deucrictibant shows safety and tolerability in Phase 2 HAE study
3M ago
Pharvaris provides business update, expands deucrictibant development program
Premium
The Fly
Pharvaris provides business update, expands deucrictibant development program
3M ago
Pharvaris Advances HAE Treatment Trials
Premium
Company Announcements
Pharvaris Advances HAE Treatment Trials
3M ago
Pharvaris Schedules 2024 Shareholder Meeting
PremiumCompany AnnouncementsPharvaris Schedules 2024 Shareholder Meeting
6M ago
Pharvaris Showcases Promising HAE Treatment Data
Premium
Company Announcements
Pharvaris Showcases Promising HAE Treatment Data
6M ago
Pharvaris’ deucrictibant shows positive results in HAE attack prevention
Premium
The Fly
Pharvaris’ deucrictibant shows positive results in HAE attack prevention
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100